Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFBC
3476
Sound Financial Bancorp
SFBC
$112M
| $2.13M | ﹤0.01% |
42,377
| – | – |
|
|
WW
3477
DELISTED
WW International
WW
| $2.12M | ﹤0.01% |
4,061,617
-8,647
| -0.2% | -$7.51K |
|
3478
Cue Biopharma
CUE
$113M
| $2.11M | ﹤0.01% |
77,195
+8,656
| +13% | +$321K |
|
|
NB
3479
NioCorp Developments
NB
$619M
| $2.09M | ﹤0.01% |
1,059,589
+123,539
| +13% | +$248K |
|
3480
Central Plains Bancshares
CPBI
$83.9M
| $2.08M | ﹤0.01% |
139,574
+106,906
| +327% | +$1.58M |
|
3481
iShares Core Dividend Growth ETF
DGRO
$42.7B
| $2.07M | ﹤0.01% |
33,471
+590
| +2% | +$37K |
|
3482
Assembly Biosciences
ASMB
$498M
| $2.06M | ﹤0.01% |
215,983
+15,525
| +8% | +$203K |
|
3483
Telkom Indonesia
TLK
$14.5B
| $2.06M | ﹤0.01% |
139,378
+2,529
| +2% | +$39.5K |
|
3484
Pixelworks
PXLW
$38.2M
| $2.06M | ﹤0.01% |
273,344
-103
| -0% | -$948 |
|
3485
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
| $2.04M | ﹤0.01% |
21,819
+14
| +0.1% | +$1.29K |
|
|
CBNA
3486
Chain Bridge Bancorp
CBNA
$299M
| $2.04M | ﹤0.01% |
85,897
+50,851
| +145% | +$1.22M |
|
3487
Milestone Scientific
MLSS
$35.3M
| $2.04M | ﹤0.01% |
2,182,871
+3,187
| +0.1% | +$3.5K |
|
3488
Apyx Medical
APYX
$173M
| $2.02M | ﹤0.01% |
1,475,772
| – | – |
|
3489
Monopar Therapeutics
MNPR
$726M
| $2.01M | ﹤0.01% |
55,234
-1,275
| -2% | -$45.9K |
|
3490
The Oncology Institute
TOI
$486M
| $2M | ﹤0.01% |
1,750,714
-3,672
| -0.2% | -$2.84K |
|
3491
Context Therapeutics
CNTX
$55.1M
| $1.99M | ﹤0.01% |
3,253,467
-1,996
| -0.1% | -$1.74K |
|
3492
Metagenomi Therapeutics
MGX
$44.8M
| $1.98M | ﹤0.01% |
1,457,187
+188,798
| +15% | +$450K |
|
3493
Elicio Therapeutics
ELTX
$73.5M
| $1.98M | ﹤0.01% |
321,694
+75,871
| +31% | +$588K |
|
3494
Comstock
LODE
$208M
| $1.98M | ﹤0.01% |
809,891
+441,132
| +120% | +$1.47M |
|
|
TPIC
3495
DELISTED
TPI Composites
TPIC
| $1.96M | ﹤0.01% |
2,435,576
-7,975
| -0.3% | -$10.4K |
|
|
FIRY
3496
Firy Inc
FIRY
$148M
| $1.96M | ﹤0.01% |
434,449
| – | – |
|
3497
Inuvo
INUV
$15.1M
| $1.95M | ﹤0.01% |
549,566
| – | – |
|
3498
Cytosorbents Corp
CTSO
$22.7M
| $1.95M | ﹤0.01% |
1,949,551
| – | – |
|
3499
BGSF Inc
BGSF
$59.5M
| $1.94M | ﹤0.01% |
527,160
| – | – |
|
3500
Bluerock Homes Trust
BHM
$35.3M
| $1.94M | ﹤0.01% |
170,402
| – | – |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.